Physician profile
Deepal Shah
NPI 1447566740
$2,023.24
in general payments reported to CMS, 2019-2025
24 companies · $1,635 in 2025
The $1,635 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $388 · 2025: $1,635.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,023.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,023.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $405.27 | 2024-2025 | |
| Ucb, INC. | $378.07 | 2024-2025 | Briviact, Rystiggo, Nayzilam |
| Sk Life Science, INC. | $205.88 | 2024-2025 | |
| Emd Serono, INC. | $168.29 | 2025 | Mavenclad |
| Novartis Pharmaceuticals Corporation | $147.60 | 2024-2025 | |
| Neurocrine Biosciences, INC. | $73.05 | 2025 | |
| Axsome Therapeutics, INC. | $67.97 | 2025 | Symbravo |
| Pfizer INC. | $67.45 | 2025 | |
| Abbott Laboratories | $60.39 | 2025 | Infinity |
| Boston Scientific Corporation | $55.65 | 2024-2025 | Lux-Dx Insertable Cardiac Monitor, Watchman Flx |
| Biogen, INC. | $50.77 | 2025 | Tysabri, Vumerity |
| Grifols USA, LLC | $45.09 | 2025 | Gamunex-C |
| Exact Sciences Corporation | $41.47 | 2025 | Cologuard Collection Kit |
| Janssen Biotech, INC. | $40.78 | 2025 | |
| Argenx US, INC. | $34.19 | 2025 | Vyvgart Hytrulo |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $26.37 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Genentech USA, INC. | $22.08 | 2025 | Ocrevus Zunovo |
| Eisai INC. | $21.73 | 2024 | |
| Life Molecular Imaging LTD | $21.24 | 2025 | Neuraceq |
| Amgen INC. | $19.85 | 2025 | Uplizna |
| Nalu Medical, INC. | $19.11 | 2025 | Nalu Neurostimulation System |
| Amneal Pharmaceuticals LLC | $18.88 | 2025 | Crexont |
| Viiv Healthcare Company | $16.86 | 2025 | Dovato |
| Lundbeck LLC | $15.20 | 2025 | Rexulti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deepal Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.